BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21600278)

  • 1. p38 MAPK activation is required for esculetin-induced inhibition of vascular smooth muscle cells proliferation.
    Yun ES; Park SS; Shin HC; Choi YH; Kim WJ; Moon SK
    Toxicol In Vitro; 2011 Oct; 25(7):1335-42. PubMed ID: 21600278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells.
    Lee B; Kim CH; Moon SK
    FEBS Lett; 2006 Oct; 580(22):5177-84. PubMed ID: 16962592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: involvement of p38 mitogen activated protein kinase.
    Moon SK; Jung SY; Choi YH; Lee YC; Patterson C; Kim CH
    J Cell Physiol; 2004 Feb; 198(2):310-23. PubMed ID: 14603533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras/ERK1 pathway regulation of p27KIP1-mediated G1-phase cell-cycle arrest in cordycepin-induced inhibition of the proliferation of vascular smooth muscle cells.
    Jung SM; Park SS; Kim WJ; Moon SK
    Eur J Pharmacol; 2012 Apr; 681(1-3):15-22. PubMed ID: 22366198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPO gene expression promotes proliferation, migration and invasion via the p38MAPK/AP-1/MMP-9 pathway by p21WAF1 expression in vascular smooth muscle cells.
    Park SL; Won SY; Song JH; Kambe T; Nagao M; Kim WJ; Moon SK
    Cell Signal; 2015 Mar; 27(3):470-8. PubMed ID: 25496832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esculetin inhibits cell proliferation through the Ras/ERK1/2 pathway in human colon cancer cells.
    Park SS; Park SK; Lim JH; Choi YH; Kim WJ; Moon SK
    Oncol Rep; 2011 Jan; 25(1):223-30. PubMed ID: 21109980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor Sp1 mediates p38MAPK-dependent activation of the p21WAF1 gene promoter in vascular smooth muscle cells by pyrrolidine dithiocarbamate.
    Moon SK; Jung SY; Kim CH
    Biochem Biophys Res Commun; 2004 Apr; 316(3):605-11. PubMed ID: 15033443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringin-induced p21WAF1-mediated G(1)-phase cell cycle arrest via activation of the Ras/Raf/ERK signaling pathway in vascular smooth muscle cells.
    Lee EJ; Moon GS; Choi WS; Kim WJ; Moon SK
    Food Chem Toxicol; 2008 Dec; 46(12):3800-7. PubMed ID: 18951945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP-response element-binding protein mediates tumor necrosis factor-alpha-induced vascular smooth muscle cell migration.
    Ono H; Ichiki T; Fukuyama K; Iino N; Masuda S; Egashira K; Takeshita A
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1634-9. PubMed ID: 15242860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
    Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of vascular smooth muscle cells to estrogen are dependent on balance between ERK and p38 MAPK pathway activities.
    Cheng B; Song J; Zou Y; Wang Q; Lei Y; Zhu C; Hu C
    Int J Cardiol; 2009 May; 134(3):356-65. PubMed ID: 18584900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
    Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1α expression.
    Xu W; Guo T; Zhang Y; Jiang X; Zhang Y; Zen K; Yu B; Zhang CY
    Exp Cell Res; 2011 May; 317(8):1083-92. PubMed ID: 20955697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p38 mitogen-activated protein kinase is involved in stress-induced phospholipase D activation in vascular smooth muscle cells.
    Min DS; Shin EY; Kim EG
    Exp Mol Med; 2002 Mar; 34(1):38-46. PubMed ID: 11989977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
    Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
    Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of esculetin on migration, invasion and matrix metalloproteinase-9 expression in TNF-α-induced vascular smooth muscle cells.
    Lee SJ; Lee US; Kim WJ; Moon SK
    Mol Med Rep; 2011; 4(2):337-41. PubMed ID: 21468574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21WAF1 Is Required for Interleukin-16-Induced Migration and Invasion of Vascular Smooth Muscle Cells via the p38MAPK/Sp-1/MMP-9 Pathway.
    Park SL; Hwang B; Lee SY; Kim WT; Choi YH; Chang YC; Kim WJ; Moon SK
    PLoS One; 2015; 10(11):e0142153. PubMed ID: 26544695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
    Yamakawa T; Eguchi S; Matsumoto T; Yamakawa Y; Numaguchi K; Miyata I; Reynolds CM; Motley ED; Inagami T
    Endocrinology; 1999 Aug; 140(8):3562-72. PubMed ID: 10433212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.